 Q BioMed Inc announced that the company closed an additional 2 million funding on October 5 this year, which will be used to support its planned uplisting to Nasdaq and operations for the next 12 months. The uplisting on a senior exchange will coincide with its proposed capital raise, satisfying the capital needs for the following year. 